Study guide

25.3 Glaucoma Surgical Procedures: Trabeculectomy, Aqueous Shunts & MIGS Devices

IJCAHPO Certified Ophthalmic Medical Technologist COMT

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: The COMT Examination, Eligibility & Certification Requirements

1.1 The 190-Question Multiple-Choice Examination & the 22 Official Content Areas 1.2 The COT Skill Evaluation & the COMT Performance Test 1.3 Eligibility Pathways, Fees, Timelines & Recertification

2 Chapter 2: General Medical Knowledge I — Ocular Anatomy & Physiology

2.1 Orbit, Eyelids, Lacrimal System, Conjunctiva & Extraocular Muscles 2.2 Cornea, Sclera, Anterior Chamber, Angle, Aqueous Dynamics & Crystalline Lens 2.3 Uvea, Retina, Vitreous, Optic Nerve, Ocular Circulation & the Visual Pathway

3 Chapter 3: General Medical Knowledge II — Eye Disease, Systemic Manifestations, Terminology & Safety

3.1 Frequently Encountered Eye Conditions by Structure & Inflammation Versus Infection 3.2 Body Systems & the Ocular Manifestations of Systemic Disease 3.3 Medical Terminology, Approved Abbreviations, Hazardous Waste & Clinic Safety

4 Chapter 4: Ophthalmic History Taking & Clinical Documentation

4.1 The Five History Domains: Ocular, Medical, Medication, Social & Family 4.2 Charting Conventions, Scribing & the Electronic Medical Record

5 Chapter 5: Visual Assessment, Accommodative Testing & Low Vision

5.1 Measuring Acuity at Every Level & in Preliterate, Illiterate and Non-Verbal Patients 5.2 Stereoacuity, Near Point of Accommodation, Near Point of Convergence & the AC/A Ratio 5.3 Low Vision Assessment, Magnification Calculation & Device Instruction

6 Chapter 6: Tonometry, Keratometry & Pupil Measurement

6.1 Goldmann Applanation Tonometry: Technique, Sources of Error & the Imbert-Fick Principle 6.2 Hand-Held Applanators, Non-Contact Tonometry, Rebound Tonometry & Disinfection 6.3 Manual & Automated Keratometry: Technique, Readings and Interpretation 6.4 Pupil Measurement, Shape, Reactivity & Evaluating Anisocoria

7 Chapter 7: Lensometry, Spectacle Optics & Prescription Analysis

7.1 Manual Lensometry: Eyepiece Focus, Neutralising Sphere, Cylinder & Axis 7.2 Neutralising Reading Adds: Bifocal, Trifocal, Progressive & Determining the Near Add 7.3 Identifying & Measuring Prism: Ground-In, Decentration, Fresnel Press-On & Slab-Off 7.4 Transposition, Spherical Equivalent, Vertex Distance & Prescription Components 7.5 The Geneva Lens Clock, Lens Materials, Progressive Markings & Spectacle Adjustment

8 Chapter 8: Refraction, Retinoscopy & Refinement

8.1 Autorefraction, Refractive Error Types & Establishing an Objective Starting Point 8.2 Streak Retinoscopy: With Motion, Against Motion, Neutralisation & Working Distance 8.3 Subjective Refinement: Fogging, Jackson Cross Cylinder, Duochrome & Binocular Balance 8.4 Near Add Determination, Vertex Recording & Refraction in Difficult Situations

9 Chapter 9: Ocular Motility, Strabismus & Advanced Optics

9.1 Ocular Kinematics: Ductions, Versions, Vergences, Hering's & Sherrington's Laws 9.2 Quantitative Strabismus Measurements: Alternate Cover Test, Prism Cover Test & Lancaster Red-Green / Hess Screen 9.3 Cranial Nerve Palsies (CN III, IV, VI), Restrictive Myopathies & Forced Duction Testing 9.4 Clinical Optics, Prentice's Rule, Slab-Off Prisms & Wavefront Aberrations

10 Chapter 10: Sensory Fusion Testing, Nystagmus, Amblyopia & Vergence Therapy

10.1 Sensory Fusion Testing: Worth 4-Dot, Maddox Rod & Bagolini Lenses 10.2 Hirschberg, Krimsky, Brückner & Fusional Vergence Amplitudes 10.3 Nystagmus, Amblyopia Therapy & Convergence Training

11 Chapter 11: Advanced Visual Fields & Neuro-Ophthalmic Evaluation

11.1 Amsler Grid & Confrontation Visual Field Testing 11.2 Automated Static Perimetry: HFA Strategies (SITA Standard, SITA Fast), Reliability Indices & Statpac Analysis 11.3 Visual Field Defect Patterns: Glaucomatous Nerve Fiber Bundle Deficits vs. Retinal Pathology 11.4 Kinetic Perimetry (Goldmann Perimetry) & Neurological Visual Pathway Defect Localization 11.5 Pupillary Pathways, RAPD Quantitation with Neutral Density Filters & Pharmacologic Testing

12 Chapter 12: Supplemental Testing — Glare, PAM, Colour Vision, Tear Film & Slit Lamp Technique

12.1 Glare Testing, Potential Acuity Meter & Contrast Sensitivity 12.2 Colour Vision: Pseudoisochromatic Plates, Farnsworth-Munsell D-15 & the 100-Hue Test 12.3 Tear Film Assessment: Schirmer, Tear Break-Up Time, Vital Dyes & Corneal Sensitivity 12.4 Slit Lamp Technique, Slit Lamp Lenses, Direct Ophthalmoscopy & Pen Light Examination 12.5 Exophthalmometry, Head & Posture Assessment and Wavefront Diagnostics

13 Chapter 13: Full-Field Electroretinography & ISCEV Protocols

13.1 Retinal Neurophysiology & Electrophysiologic Origin of Waveforms 13.2 ISCEV Standard Full-Field ERG Protocol & Electrode Systems 13.3 Dark-Adapted (Scotopic) Testing: Rod-Driven Responses & Combined Maximal Response 13.4 Light-Adapted (Photopic) Testing: Cone Response, 30-Hz Flicker & Oscillatory Potentials

14 Chapter 14: Advanced Electrophysiologic Testing (mfERG, PERG, VEP, EOG)

14.1 Multifocal Electroretinogram (mfERG): Topographic Retinal Mapping 14.2 Pattern Electroretinogram (PERG): Ganglion Cell & Macular Function 14.3 Visual Evoked Potentials (VEP): Flash, Pattern & Visual Pathway Integrity 14.4 Electrooculogram (EOG), Arden Ratio & RPE Light Peak Dynamics

15 Chapter 15: Fluorescein Angiography Principles & Technique

15.1 Fluorescein Angiography Principles, Exciter/Barrier Filters & Injection Protocol 15.2 Normal Transit Phases & Retinal/Choroidal Circulation Hemodynamics 15.3 Adverse Reactions, Patient Safety & Emergency Management

16 Chapter 16: Angiographic Interpretation & Pathology

16.1 Hyperfluorescence Mechanisms: Leakage, Staining, Pooling, Window Defects & Autofluorescence 16.2 Hypofluorescence Mechanisms: Vascular Non-Perfusion & Blocking Defects 16.3 Indocyanine Green (ICG) Angiography: Principles, Indications & Choroidal Pathology

17 Chapter 17: Advanced Fundus Imaging & Optical Coherence Tomography

17.1 Fundus Autofluorescence (FAF) & Ultra-Widefield Fundus Imaging 17.2 Spectral-Domain and Swept-Source OCT: Retinal Layer Architecture & Quantitative Analysis 17.3 Enhanced Depth Imaging (EDI-OCT) & Anterior Segment OCT (AS-OCT) 17.4 Optical Coherence Tomography Angiography (OCTA): Chorioretinal Plexuses & Biomarkers

18 Chapter 18: Ophthalmic Photography & Videography

18.1 The Fundus Camera: Optics, Alignment & Correcting Artefacts 18.2 Standard Fundus Photography: ETDRS Fields, Stereo Pairs, Red-Free & Wide-Field Imaging 18.3 Slit Lamp & Anterior Segment Photography 18.4 External Photography, Nine-Gaze Motility Documentation & Image Management

19 Chapter 19: Ophthalmic Echography (A-Scan, B-Scan & UBM)

19.1 Physics of Ophthalmic Ultrasound, Acoustic Impedance & Probe Transducers 19.2 Standardized Diagnostic A-Scan: Acoustic Spikes, Tissue Reflectivity & Attenuation 19.3 Diagnostic B-Scan Echography: Topographic, Kinetic & Quantitative Vitreoretinal Evaluation 19.4 Ultrasound Biomicroscopy (UBM): Anterior Segment Anatomy, Angle Pathology & Ciliary Body Imaging

20 Chapter 20: Biometry, Topography & Corneal Analysis

20.1 Optical Biometry vs. Immersion/Contact Ultrasound Biometry 20.2 Intraocular Lens (IOL) Power Calculation Formulas & Post-Refractive Adjustments 20.3 Corneal Topography, Scheimpflug Tomography & Keratoconus Screening 20.4 Corneal Pachymetry, Endothelial Specular Microscopy & Anterior Chamber Depth

21 Chapter 21: Rigid Gas Permeable & Specialty Lens Fitting

21.1 Rigid Gas Permeable (RGP) Material Properties, Dk/t & Oxygen Permeability 21.2 RGP Base Curve Selection, Diagnostic Fitting & Fluorescein Pattern Evaluation 21.3 Scleral Contact Lens Design, Sagittal Depth Fitting & Clearance Evaluation 21.4 Keratoconus, Irregular Corneas & Hybrid Contact Lens Systems

22 Chapter 22: Toric, Multifocal, Therapeutic Lenses & Complications

22.1 Toric Soft Contact Lens Dynamics, Stabilization Techniques & LARS Rule 22.2 Presbyopic & Multifocal Contact Lens Systems: Simultaneous vs. Translating Designs 22.3 Therapeutic Bandage Contact Lenses, Amniotic Membranes & Orthokeratology 22.4 Contact Lens-Induced Pathology, Giant Papillary Conjunctivitis & Infectious Keratitis

23 Chapter 23: Ocular Pharmacology

23.1 Routes of Drug Delivery, Prescription Components & Instillation Technique 23.2 Mydriatics, Cycloplegics, Anaesthetics & Diagnostic Agents 23.3 Glaucoma Medications: Classes, Mechanisms & Side Effects 23.4 Anti-Infectives, Corticosteroids, NSAIDs, Allergy Agents, Lubricants, Supplements & Anti-VEGF

24 Chapter 24: Microbiology & Ocular Specimen Collection

24.1 Types of Microorganisms & Pathways of Disease Transmission 24.2 Assisting with Conjunctival & Corneal Specimen Collection

25 Chapter 25: Anterior Segment, Glaucoma & Refractive Surgery

25.1 Advanced Phacoemulsification, Surgical Steps, Fluidics & Complication Management 25.2 Premium Intraocular Lenses: Toric, Multifocal, EDOF & Lens Exchange 25.3 Glaucoma Surgical Procedures: Trabeculectomy, Aqueous Shunts & MIGS Devices 25.4 Laser In Situ Keratomileusis (LASIK), PRK, SMILE & Phakic IOLs

26 Chapter 26: Vitreoretinal, Corneal & Trauma Surgery

26.1 Pars Plana Vitrectomy (PPV), Scleral Buckling & Intraocular Tamponades (Gas/Silicone Oil) 26.2 Corneal Transplantation: Penetrating Keratoplasty (PKP) & Lamellar Keratoplasty (DSAEK, DMEK, DALK) 26.3 Ocular Trauma Repair: Open Globe Management, Hyphema, Vitreous Loss & Endophthalmitis Protocol

27 Chapter 27: Surgical Asepsis, Instrumentation & Laser Procedures

27.1 Operating Room Sterilization, Aseptic Field Maintenance & Universal Precautions 27.2 Microsurgical Instrumentation, Maintenance & Sharps Safety 27.3 Ophthalmic Laser Physics, Delivery Systems & Safety (Nd:YAG, Argon/FD-Nd:YAG, SLT)

28 Chapter 28: Ophthalmic Patient Services & Education

28.1 Communicating with Patients, Families and Colleagues, and Handling Dissatisfaction 28.2 Patient Education & Counselling on Conditions, Medications, Tests and Results 28.3 Ophthalmic Emergencies, First Aid, Vital Signs & CPR 28.4 Triage, Urgency-Based Scheduling, Patient Flow & Telephone Management 28.5 Dressings and Shields, Prosthetics, Legal Forms, Referrals & Reimbursement Support

29 Chapter 29: Clinic Operations — Equipment Maintenance, Ethics, Coding & Compliance

29.1 Equipment Maintenance, Calibration, Emergency Equipment & Inventory 29.2 Confidentiality, Informed Consent, Scope of Practice & Ethical Standards 29.3 Coding, Scribing Compliance, Quality Assurance & Regulatory Requirements

25.3 Glaucoma Surgical Procedures: Trabeculectomy, Aqueous Shunts & MIGS Devices

Key Takeaways Explain This Topic AI

Trabeculectomy lowers IOP by creating a guarded partial-thickness scleral fistula into the subconjunctival space; adjunctive antimetabolites (Mitomycin C or 5-Fluorouracil) are essential to prevent episcleral fibroblastic proliferation.

Mitomycin C (MMC, 0.2–0.4 mg/mL) permanently arrests fibroblast replication via DNA alkylation, whereas 5-Fluorouracil (5-FU, 50 mg/mL) acts as an S-phase antimetabolite inhibiting thymidylate synthase.

Aqueous drainage shunts are divided into valved devices (Ahmed), which contain a membrane flow restrictor that opens at 8 to 12 mmHg to prevent early hypotony, and non-valved devices (Baerveldt), which mandate temporary surgical ligature to avoid acute chamber collapse.

Minimally Invasive Glaucoma Surgery (MIGS) devices provide an enhanced safety profile over filtering surgery, categorizing into trabecular bypass (iStent, Hydrus), suprachoroidal shunting, and subconjunctival drainage (XEN Gel Stent).

Postoperative bleb evaluation utilizes standardized scales (e.g., Moorfields, Indiana) to grade height, vascularity, and extent, allowing rapid differentiation between normal microcystic filtering blebs, blebitis, and bleb-related endophthalmitis.

Last updated: September 2026

Glaucoma Surgical Procedures: Trabeculectomy, Aqueous Shunts & MIGS Devices

Core Clinical Mandate: When progressive glaucomatous optic neuropathy cannot be arrested by maximally tolerated medical therapy and laser trabeculoplasty, incisional surgical intervention is required. The ophthalmic medical technologist must understand the microsurgical steps, fluidic resistances, and post-surgical surveillance protocols for trabeculectomies, tube shunts, and micro-invasive glaucoma surgeries (MIGS).

Trabeculectomy: Surgical Architecture, Flap Mechanics & Antimetabolites

Originally developed by Cairns in 1968, trabeculectomy remains the historical reference standard for incisional glaucoma filtration. It creates a guarded, partial-thickness fistula from the anterior chamber into the sub-Tenon's / subconjunctival space, bypassing the obstructed trabecular meshwork to form a subconjunctival filtering bleb .

Step-by-Step Surgical Sequence

Conjunctival Peritomy:

Fornix-Based: Incision made at the corneal limbus, reflecting the conjunctiva and Tenon's capsule backward toward the fornix. Provides superior surgical exposure and facilitates diffuse posterior antimetabolite placement. Requires meticulous, watertight limbal closure.

Limbus-Based: Incision made 8 mm to 10 mm posterior to the limbus in the fornix, dissecting forward to the limbus. Eliminates risk of limbal edge leak but increases technical difficulty and carries a higher risk of surgical scarring near the filtration site.

Scleral Flap Creation: A partial-thickness scleral flap (one-third to one-half scleral thickness, typically 3.0 mm × 3.0 mm rectangular, triangular, or trapezoidal) is dissected anteriorly into clear cornea. The flap provides guarded physical resistance against unchecked aqueous egress, preventing immediate post-surgical hypotony.

Antimetabolite Application: Sponges soaked in antifibrotic agents are applied under Tenon's capsule and the scleral flap, followed by vigorous irrigation with 20 to 30 mL of balanced salt solution (BSS).

Sclerectomy (Ostium) & Peripheral Iridectomy (PI): A deep block of trabecular meshwork and inner sclera (approximately 1.0 mm × 1.5 mm) is excised beneath the flap using a Kelly punch. A surgical peripheral iridectomy is performed through the ostium using Vannas scissors and Bonn forceps. The PI prevents the peripheral iris root from prolapsing forward and blocking the internal ostium.

Scleral Flap Suturing: The flap is secured with interrupted 10-0 nylon sutures. Sutures may be placed as releasable sutures (externalized loops that can be removed at the slit lamp) or titrated postoperatively using an argon laser with a Hoskins or Blumenthal lens ( laser suture lysis ).

Conjunctival Closure & Seidel Testing: Conjunctiva is closed with 10-0 nylon or 8-0 Vicryl. Watertight integrity is verified by placing 2% sodium fluorescein over the suture line under cobalt blue illumination (Seidel test).

Antimetabolites in Filtration Surgery: Mitomycin C vs. 5-Fluorouracil

Postoperative wound healing and subconjunctival fibroblastic scarring represent the primary cause of trabeculectomy failure. Antimetabolites prevent this healing response:

Feature Mitomycin C (MMC) 5-Fluorouracil (5-FU)

Pharmacologic Class Alkylating antibiotic isolated from Streptomyces caespitosus Pyrimidine analog (fluorinated pyrimidine)

Mechanism of Action DNA cross-linking ; forms covalent bonds with guanine bases, permanently inhibiting DNA replication, mitosis, and protein synthesis Inhibits thymidylate synthase (via active metabolite FdUMP), halting DNA synthesis selectively during the S-phase of the cell cycle

Duration / Potency Highly potent; permanent cellular apoptosis / irreversible arrest Less potent; reversible cytostatic action; requires repeated cell cycle exposure

Standard Clinical Dosage 0.2 mg/mL to 0.4 mg/mL applied topically via sponges for 1 to 3 minutes 50 mg/mL applied intraoperatively via sponges for 5 minutes, or 5 mg subconjunctival injections post-op

Bleb Morphology Induced Thin, avascular, translucent, cystic blebs More cellular, moderately vascular, thicker-walled blebs

Primary Complication Risk Late bleb leakage, chronic hypotony, blebitis, and endophthalmitis Corneal epithelial toxicity (punctate epithelial keratopathy, corneal erosions)

Loading diagram... Glaucoma Outflow Anatomy & Surgical Pathways

  • Bleb Evaluation, Morphological Grading & Postoperative Triage
  • Clinical Bleb Morphology: Standardized Grading Scales

Postoperative bleb surveillance relies on standardized classification systems, such as the Moorfields Bleb Grading System (MBGS) and the Indiana Bleb Appearance Grading Scale (IBAGS) , which evaluate four primary parameters:

Bleb Height: Classified as low (flat, scarred), moderate, or high (cystic).

Bleb Extent (Area): Measured in clock hours or horizontal millimeters of subconjunctival spread.

Vascularity: Graded from 0 (completely avascular, porcelain white) to 3 or 4 (severely hyperemic/erythematous). Moderate, diffuse, microcystic vascularity is ideal.

Seidel Leakage: Graded as negative, pinpoint leak, or streaming leak.

Postoperative Bleb Complications

Early Hypotony with Shallow Chamber: Occurs within days post-op due to overfiltration or wound leak. If the anterior chamber is flat (corneo-lenticular touch), the lens capsule will opacify and endothelial cells will rapidly perish. Managed with cycloplegics, pressure patch, oversized bandage contact lens, OVD injection into the AC, or suture revision.

Failing / Encapsulated Bleb (Tenon's Cyst): Characterized by high IOP, a tense, localized, elevated, thick-walled bleb with engorged episcleral vessels occurring at 2 to 6 weeks. Managed with aqueous suppressants, digital ocular massage, or slit-lamp bleb needling combined with 5-FU or MMC injection.

Blebitis vs. Bleb-Related Endophthalmitis (BRE):

Blebitis: Localized infection confined strictly to the filtering bleb without vitreous involvement. Presents with pain, conjunctival injection, and a milky-white, purulent bleb ("white bleb with red eye"). Anterior chamber contains mild cells without hypopyon or vitritis. Treated emergently with intensive topical fortified antibiotics (vancomycin 25–50 mg/mL and ceftazidime 50 mg/mL or tobramycin 14 mg/mL alternating every 30–60 minutes) and oral fluoroquinolones.

Bleb-Related Endophthalmitis: Extension of bacterial infection into the intraocular cavities. Characterized by severe aching pain, profound visual loss, hypopyon, and dense vitritis. Virulent pathogens include Streptococcus pneumoniae , Staphylococcus aureus , and Haemophilus influenzae . Requires emergent vitreous tap and intravitreal antibiotic injection (vancomycin 1 mg/0.1 mL + ceftazidime 2.25 mg/0.1 mL), or immediate pars plana vitrectomy (PPV).

Aqueous Drainage Implants (Glaucoma Tube Shunts)

Aqueous drainage implants divert aqueous humor through a flexible silicone tube into an equatorial reservoir plate anchored 8 mm to 10 mm posterior to the limbus. Fluid passes across the surrounding semi-permeable fibrous capsule into orbital capillaries and lymphatics.

Valved vs. Non-Valved Aqueous Shunts

Feature Valved Shunt (Ahmed Glaucoma Valve - AGV) Non-Valved Shunt (Baerveldt / Molteno)

Model Examples Ahmed FP7 (polypropylene or silicone plate, 184 mm²) Baerveldt BG-101-350 (350 mm²) or BG-102-250 (250 mm²)

Flow Restrictor Mechanism Built-in silicone elastomer membrane valve based on the Venturi principle; opens at 8 to 12 mmHg Zero intrinsic flow restriction ; completely open silicone conduit

Intraoperative Ligation Not required ; device is primed with BSS before insertion Mandatory surgical ligation using a 7-0 or 8-0 Vicryl suture to occlude lumen

Early Postoperative IOP Immediate IOP lowering upon implantation Elevated IOP for 4–6 weeks until Vicryl ligature spontaneously dissolves

Early Hypotony Risk Very low (valve closes if IOP < 8 mmHg) Catastrophic if ligature leaks or is omitted

Long-Term IOP Control Good; higher incidence of early "hypertensive phase" (4–8 weeks) Superior long-term IOP lowering due to larger plate surface area (350 mm²)

Surgical Details & Complication Profiles

Plate Fixation: Sutured to sclera in the equatorial space between adjacent rectus muscles (superotemporal quadrant is preferred to avoid the superior oblique tendon and avoid inferior strabismus complications).

Tube Entry & Donor Patch Grafts: The tube enters the anterior chamber through a 23-gauge needle tract angled parallel to the iris plane. In pseudophakic eyes with compromised anterior chambers, the tube can be inserted into the ciliary sulcus or pars plana (the latter requiring complete pars plana vitrectomy). The extraocular subconjunctival portion of the tube must be covered with a patch graft (donor sclera, processed pericardium [Tutoplast], or donor cornea) to prevent tube erosion through the conjunctiva.

Tube-Cornea Touch: If the tube is placed too anteriorly, it strikes the corneal endothelium, inducing localized corneal edema and progressive endothelial cell loss requiring tube repositioning or endothelial keratoplasty.

Minimally Invasive Glaucoma Surgery (MIGS)

Minimally Invasive Glaucoma Surgery (MIGS) refers to a class of micro-incisional surgical procedures designed to lower intraocular pressure with an exceptional safety profile, rapid recovery, and minimal anatomical disruption compared to filtering surgery. Most MIGS procedures are performed ab interno through a clear corneal incision under intraoperative direct gonioscopic visualization. Classification of MIGS by Anatomical Outflow Mechanism:

  • 1. TRABECULAR OUTFLOW (Schlemm's Canal Bypass / Scaffold)
  • ├── iStent / iStent inject (Titanium micro-bypass stents)
  • ├── Hydrus Microstent (8-mm nitinol scaffold spanning 90°)
  • ├── Kahook Dual Blade / Trabectome (Excisional goniotomy)
  • └── OMNI / GATT (360° viscodilation + transluminal trabeculotomy)
  • 2. SUPRACHOROIDAL OUTFLOW (Uveoscleral Pathway)
  • ├── MINIject (Flexible biocompatible porous silicone)
  • └── CyPass Micro-Stent (WITHDRAWN 2018 due to endothelial cell loss)
  • 3. SUBCONJUNCTIVAL FILTRATION
  • ├── XEN 45 Gel Stent (Ab interno porcine cross-linked gelatin)
  • └── Preserflo MicroShunt (Ab externo SIBS biomaterial + MMC)
  • 1. Trabecular Meshwork Bypass and Schlemm's Canal Scaffolds

Because the juxtacanalicular trabecular meshwork provides the primary resistance to aqueous humor outflow in primary open-angle glaucoma, bypassing this tissue restores physiological outflow into collector channels:

iStent inject: Consists of two heparin-coated titanium micro-stents (each 360 µm long) implanted ab interno through the trabecular meshwork into Schlemm's canal, spaced 2 to 3 clock hours apart under gonioscopic view.

Hydrus Microstent: An 8 mm curved, flexible scaffold made of nickel-titanium alloy (nitinol). It is inserted into Schlemm's canal, dilating and scaffolding approximately 90° (3 clock hours) of the canal to expose multiple collector channel ostia while maintaining a patent inlet directly into the anterior chamber.

Goniotomy and Trabeculotomy (KDB & GATT):

Kahook Dual Blade (KDB): An engineered footplate and dual parallel blades excise a full-thickness strip of diseased trabecular meshwork over 90° to 120°, opening direct access to the canal without leaving an implant.

GATT (Gonioscopy-Assisted Transluminal Trabeculotomy): A 5-0 prolene suture or illuminated microcatheter (iTrack) is threaded 360° through Schlemm's canal and then pulled tight to cleave the entire trabecular meshwork circumferentially.

2. Suprachoroidal Shunts & The CyPass Withdrawal

Suprachoroidal devices channel aqueous from the anterior chamber into the suprachoroidal space, utilizing the physiological uveoscleral outflow pathway and the negative hydrostatic pressure gradient between the anterior chamber and the suprachoroidal space.

The CyPass Clinical Lesson: The CyPass Micro-Stent was FDA approved in 2016 and voluntarily withdrawn from the global market in 2018 following the 5-year COMPASS-XT study . The trial revealed statistically significant, progressive corneal endothelial cell loss directly correlated with the number of retention rings protruding anteriorly into the anterior chamber. Physical proximity to the endothelium and micro-movement of the rigid polyimide tube induced mechanical endothelial injury.

Modern Suprachoroidal Technology: The MINIject utilizes a soft, flexible, porous silicone material (Star BioMaterial) that conforms to suprachoroidal anatomy without rigid anterior chamber protrusion.

3. Subconjunctival Gelatin Stents: The XEN 45

The XEN Gel Stent is a 6.0 mm flexible tube made of porcine-derived cross-linked gelatin, inserted ab interno from the anterior chamber into the subconjunctival space.

Hagen-Poiseuille Physics: The internal lumen diameter is precisely 45 µm . According to the Hagen-Poiseuille equation (where fluid resistance is inversely proportional to the fourth power of the radius, R ∝ 1 / r 4 R \propto 1/r^4 R ∝ 1/ r 4 ), a 6 mm tube with a 45 µm lumen generates an intrinsic fluid resistance of 6 to 8 mmHg at physiological aqueous flow rates (2 to 3 µL/min). This built-in resistance physically prevents postoperative hypotony without requiring scleral flap suturing.

Antifibrotic Requirement: Like trabeculectomy, subconjunctival gelatin stents require intraoperative subconjunctival Mitomycin C to prevent bleb encapsulation and failure.